Skip to main content
Premium Trial:

Request an Annual Quote

Gen-Probe's Q1 Product Sales Rise 11 Percent

NEW YORK (GenomeWeb News) – Gen-Probe reported after the close of the market on Thursday that its overall revenues declined around 5 percent, but its product sales increased 11 percent year over year.

The San Diego-based molecular diagnostics firm brought in revenues of $116.2 million for the three-month period ended March 31, down from $122.6 million for the first quarter of 2008. However, Gen-Probe noted that the Q1 2008 results included the last of three payments to the firm from Bayer related to patent infringement litigation, which had added $16.4 million in revenue.

Gen-Probe's product sales for the period were $112.5 million versus $101.5 million for the first quarter of 2008. Its collaborative research revenue was $1.7 million versus $2.5 million the year before, and its royalty and license revenue dropped to $2 million from $18.6 million, due to the payment the year before from Bayer.

The firm said that its clinical diagnostic products sales increased 14 percent to $59.6 million from $52.5 million, and its blood screening products rose 8 percent to $52.9 million from $49 million.

Gen-Probe's net income declined to $25.7 million, or $.48 per share, from $31.9 million, or $.58 per share.

Its R&D expenses increased 8 percent to $25 million from 423.1 million, while its SG&A spending increased 4 percent to $24.8 million from $23.9 million.

Gen-Probe finished the quarter with $286.2 million in cash and cash equivalents, and another $366.4 million in marketable securities.

The firm anticipates reporting total 2009 revenues of between $490 million and $510 million and EPS of between $1.72 and $1.90.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.